We are live on
!
Find out more
BCAM
Boston Common Asset Management Portfolio holdings
AUM
$1.69B
1-Year Est. Return
28.29%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+28.29%
3 Year Est. Return
+54.94%
5 Year Est. Return
+54.02%
10 Year Est. Return
+260.31%
AUM
$802M
AUM Growth
+$42.8M
(+5.6%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-1.47%
Top 10 Holdings %
Top 10 Hldgs %
29.13%
Holding
202
New
15
Increased
102
Reduced
54
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$3.67M |
| 2 |
Trip.com Group
TCOM
|
+$3.05M |
| 3 |
Oracle
ORCL
|
+$2.16M |
| 4 |
Albemarle
ALB
|
+$1.44M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$10.9M |
| 2 |
Sociedad Química y Minera de Chile
SQM
|
+$5.35M |
| 3 |
Equifax
EFX
|
+$4.61M |
| 4 |
Alibaba
BABA
|
+$4.11M |
| 5 |
Toronto Dominion Bank
TD
|
+$2.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 14% |
| 3 | Healthcare | 13.98% |
| 4 | Consumer Discretionary | 8.56% |
| 5 | Miscellaneous | 8% |
Similar funds
KFGK
CWG
MCM
AFM
BW
GAI
TP
Boston Common Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, Boston Common Asset Management held 202 positions worth $802M, up 5.6% from $759M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Boston Common Asset Management's Q3 2017 filing shows 15 new, 102 increased, 54 reduced and 13 closed positions. Its largest new stake was Berkshire Hathaway Class A: 5 shares worth $1.37M. The largest sale was Teva Pharmaceuticals, an estimated $10.9M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Boston Common Asset Management's largest Q3 2017 buy was Berkshire Hathaway Class A: 5 shares worth $1.37M.
- Boston Common Asset Management added most to Applied Materials in Q3 2017, an estimated $3.67M increase.
- Boston Common Asset Management's biggest Q3 2017 reduction was Sociedad Química y Minera de Chile, cutting an estimated $5.35M.
- Boston Common Asset Management fully exited Teva Pharmaceuticals in Q3 2017, selling an estimated $10.9M.
- Boston Common Asset Management's ten largest holdings make up 29% of its $802M portfolio in Q3 2017.
- Boston Common Asset Management opened 15 new positions and closed 13 in Q3 2017.
- Boston Common Asset Management's portfolio value rose 5.6% quarter-over-quarter to $802M.
Based on Boston Common Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.